Literature DB >> 6159879

Optic nerve fast axonal transport abnormalities in primates. Occurrence after short posterior ciliary artery occlusion.

R L Radius.   

Abstract

Fast axonal transport abnormalities in primate (Aotus trivirgatus) optic nerve were studied in ten eyes at various intervals after occlusion of the lateral short posterior ciliary circulation. Evidence of focal axonal ischemia, as indicated by swelling of mitochondria and dissolution of cytoplasmic detail, was noted as early as one hour after occlusion. Accumulation of mitochondria, microvesicles, and dense bodies, indicating focal interruption of axonal transport mechanisms, was noted in eyes examined at 2, 4, and 6 hours. This accumulation of organelles was limited to the region of the lamina cribrosa. Nerve head abnormalities were not seen in two eyes studied at two weeks.

Entities:  

Mesh:

Year:  1980        PMID: 6159879     DOI: 10.1001/archopht.1980.01020040870017

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma.

Authors:  M Emre; S Orgül; T Haufschild; S G Shaw; J Flammer
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

Review 2.  Optic nerve head biomechanics in aging and disease.

Authors:  J Crawford Downs
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

3.  Hyperintense optic nerve heads on diffusion-weighted imaging: a potential imaging sign of papilledema.

Authors:  R Viets; M Parsons; G Van Stavern; C Hildebolt; A Sharma
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-31       Impact factor: 3.825

4.  Ischaemia in the Zinn-Haller circle and glaucomatous optic neuropathy in macaque monkeys.

Authors:  Mari Hiraoka; Kenichi Inoue; Taihei Ninomiya; Masahiko Takada
Journal:  Br J Ophthalmol       Date:  2012-01-04       Impact factor: 4.638

5.  A Novel Tree Shrew (Tupaia belangeri) Model of Glaucoma.

Authors:  Brian C Samuels; John T Siegwart; Wenjie Zhan; Lisa Hethcox; Melissa Chimento; Ryan Whitley; J Crawford Downs; Christopher A Girkin
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-06-01       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.